XML 56 R37.htm IDEA: XBRL DOCUMENT v3.25.0.1
Inventories, Net (Tables)
12 Months Ended
Dec. 31, 2024
Inventory Disclosure [Abstract]  
Schedule of Inventory, Current
The Company's net inventories consisted of the following as of December 31:
20242023
Raw materials$11,982,045 $12,619,092 
Consigned inventory126,090 149,701 
Finished goods, net of reserve2,897,359 4,645,098 
Total inventories15,005,494 17,413,891 
less non-current inventories(11,005,499)(12,804,529)
Total inventories classified as current$3,999,995 $4,609,362 
Schedule of Inventory, Noncurrent
The Company's non-current inventories consisted of the following as of December 31:
20242023
Vibativ Raw Materials$6,180,347 $6,611,426 
Vibativ Finished Goods183,057 810,454 
Kristalose Raw Materials2,672,720 3,263,515 
Vaprisol Raw Materials1,172,849 1,170,641 
Caldolor Finished Goods77,382 67,307 
Sancuso Raw Materials458,684 574,502 
Acetadote Raw Materials23,915 — 
Omeclamox69,622 — 
Study Drug Raw Materials166,923 203,383 
Other Products— 103,300 
Total non-current inventory$11,005,499 $12,804,529